Flow Cytometric Analysis of Circulating Microparticles in Plasma

被引:263
|
作者
Orozco, Aaron F. [1 ]
Lewis, Dorothy E. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA
关键词
quantitation of plasma microparticles; polychromatic flow cytometric analysis; Western blotting polyclonal antibodies; II TYPE-1 RECEPTOR; BREAST-CANCER PATIENTS; ENDOTHELIAL MICROPARTICLES; APOPTOTIC BODIES; NUCLEIC-ACIDS; IN-VITRO; T-CELLS; ACTIVATION; VESICLES; PLATELET;
D O I
10.1002/cyto.a.20886
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microparticles, which include exosomes, micro-vesicles, apoptotic bodies and apoptotic microparticles, are small (0.05 - 3 mu m in diameter), membranous vesicles that can contain DNA, RNA, miRNA, intracellular proteins and express extracellular surface markers from the parental cells. They can be secreted from intracellular multivesicular bodies or released from the surface of blebbing membranes. Circulating microparticles are abundant in the plasma of normal individuals and can be derived from circulating blood cells such as platelets, red blood cells and leukocytes as well as from tissue sources, such as endothelial and placental tissues. Elevated levels of microparticles are associated with various diseases such as thrombosis (platelet microparticles), congestive heart failure (endothelial microparticles), breast cancer patients (leukocyte microparticles) and women with preeclampsia (syncytiotrophoblast microparticles). Although microparticles can be detected by microscopy, enzyme-linked immunoassays and functional assays, flow cytometry is the preferred method because of the ability to quantitate (fluorescent bead- or flow rate-based method) and because of polychromatic capabilities. However, standardization of pre-analytical and analytical modus operandi for isolating, enumerating and fluorescent labeling of microparticles remains a challenge. The primary focus of this article is to review the preliminary steps required to optimally study circulating in vivo microparticles which include: 1) centrifugation speed used, 2) quantitation of microparticles before antibody labeling, 3) levels of fluorescence intensity of antibody-labeled microparticles, 4) polychromatic flow cytometric analysis of microparticle sub-populations and 5) use of polyclonal antibodies designed for Western blotting for flow cytometry. These studies determine a roadmap to develop microparticles as biomarkers for a variety of conditions. (C) 2010 International Society for Advancement of Cytometry
引用
收藏
页码:502 / 514
页数:13
相关论文
共 50 条
  • [41] Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay
    Ayers, Lisa
    Kohler, Malcolm
    Harrison, Paul
    Sargent, Ian
    Dragovic, Rebecca
    Schaap, Marianne
    Nieuwland, Rienk
    Brooks, Susan A.
    Ferry, Berne
    THROMBOSIS RESEARCH, 2011, 127 (04) : 370 - 377
  • [42] Novel Flow Cytometric Analysis of the Blood-Brain Barrier
    Williams, Dionna W.
    Tesfa, Lydia
    Berman, Joan W.
    CYTOMETRY PART A, 2015, 87A (10) : 897 - 907
  • [43] Multivariate analysis of flow cytometric data using decision trees
    Simon, Svenja
    Guthke, Reinhard
    Kamradt, Thomas
    Frey, Oliver
    FRONTIERS IN MICROBIOLOGY, 2012, 3
  • [44] Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
    Juno, Jennifer A.
    Boily-Larouche, Genevieve
    Lajoie, Julie
    Fowke, Keith R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (89):
  • [45] Perfusion microvessel density in the cerebral cortex of septic rats is negatively correlated with endothelial microparticles in circulating plasma
    Wang, Zhenzhou
    Liu, Jingfeng
    Liu, Xi
    Guo, Xinjie
    Li, Tian
    Pang, Ran
    Duan, Meili
    METABOLIC BRAIN DISEASE, 2021, 36 (05) : 1029 - 1036
  • [46] Perfusion microvessel density in the cerebral cortex of septic rats is negatively correlated with endothelial microparticles in circulating plasma
    Zhenzhou Wang
    Jingfeng Liu
    Xi Liu
    Xinjie Guo
    Tian Li
    Ran Pang
    Meili Duan
    Metabolic Brain Disease, 2021, 36 : 1029 - 1036
  • [47] Circulating microparticles in cardiovascular disease: going on stage!
    Fernandez, Mauricio
    Calligaris, Sebastian D.
    BIOMARKERS, 2019, 24 (05) : 423 - 428
  • [48] Circulating microparticles in neuropsychiatric systemic lupus erythematosus
    Crookston, Kendall P.
    Sibbitt, Wilmer L., Jr.
    Chandler, Wayne. L.
    Qualls, Clifford R.
    Roldan, Carlos A.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (01) : 72 - 80
  • [49] Circulating endothelial microparticles in female migraineurs with aura
    Liman, Thomas G.
    Bachelier-Walenta, Katrin
    Neeb, Lars
    Rosinski, Jana
    Reuter, Uwe
    Boehm, Michael
    Endres, Matthias
    CEPHALALGIA, 2015, 35 (02) : 88 - 94
  • [50] Circulating Microparticles in Children With Sleep Disordered Breathing
    Kim, Jinkwan
    Bhattacharjee, Rakesh
    Kheirandish-Gozal, Leila
    Spruyt, Karen
    Gozal, David
    CHEST, 2011, 140 (02) : 408 - 417